These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

343 related items for PubMed ID: 23014668

  • 21. New oral anticoagulants after acute coronary syndrome.
    Bennaghmouch N, Ten Berg JM.
    Best Pract Res Clin Haematol; 2013 Jun; 26(2):141-50. PubMed ID: 23953902
    [Abstract] [Full Text] [Related]

  • 22. Clinical experience with novel oral anticoagulants for thromboprophylaxis after elective hip and knee arthroplasty.
    Messerschmidt C, Friedman RJ.
    Arterioscler Thromb Vasc Biol; 2015 Apr; 35(4):771-8. PubMed ID: 25767271
    [Abstract] [Full Text] [Related]

  • 23. Apixaban and rivaroxaban safety after hip and knee arthroplasty: a meta-analysis.
    Alves C, Batel-Marques F, Macedo AF.
    J Cardiovasc Pharmacol Ther; 2012 Sep; 17(3):266-76. PubMed ID: 22134134
    [Abstract] [Full Text] [Related]

  • 24. Efficacy and safety of dabigatran etexilate for the prevention of venous thromboembolism following total hip or knee arthroplasty. A meta-analysis.
    Wolowacz SE, Roskell NS, Plumb JM, Caprini JA, Eriksson BI.
    Thromb Haemost; 2009 Jan; 101(1):77-85. PubMed ID: 19132192
    [Abstract] [Full Text] [Related]

  • 25. Apixaban and rivaroxaban decrease deep venous thrombosis but not other complications after total hip and total knee arthroplasty.
    Russell RD, Huo MH.
    J Arthroplasty; 2013 Oct; 28(9):1477-81. PubMed ID: 23540535
    [Abstract] [Full Text] [Related]

  • 26. Rivaroxaban and dabigatran etexilate: two new oral anticoagulants for extended postoperative prevention of venous thromboembolism after elective total hip arthroplasty.
    Borris LC.
    Arch Orthop Trauma Surg; 2010 May; 130(5):583-9. PubMed ID: 19565250
    [Abstract] [Full Text] [Related]

  • 27. Oral rivaroxaban for the prevention of symptomatic venous thromboembolism after elective hip and knee replacement.
    Eriksson BI, Kakkar AK, Turpie AG, Gent M, Bandel TJ, Homering M, Misselwitz F, Lassen MR.
    J Bone Joint Surg Br; 2009 May; 91(5):636-44. PubMed ID: 19407299
    [Abstract] [Full Text] [Related]

  • 28. [Direct acting oral anticoagulants in venous thromboembolism].
    Walti C, Bächli E.
    Praxis (Bern 1994); 2015 Jul 22; 104(15):771-80. PubMed ID: 26204334
    [No Abstract] [Full Text] [Related]

  • 29. [Cost-effectiveness analysis of apixaban compared to dabigatran in the prevention of venous thromboembolism in patients subjected to total knee or hip replacement].
    Gómez-Cerezo JF, Gómez-Arrayás I, Suárez-Fernández C, Betegón-Nicolás L, de Salas-Cansado M, Rubio-Terrés C.
    Rev Esp Cir Ortop Traumatol; 2012 Jul 22; 56(6):459-70. PubMed ID: 23594943
    [Abstract] [Full Text] [Related]

  • 30. New oral anticoagulants for non-valvular atrial fibrillation--safety issues.
    Barry M.
    Ir Med J; 2013 Mar 22; 106(3):69. PubMed ID: 23951972
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Management consensus guidance for the use of rivaroxaban--an oral, direct factor Xa inhibitor.
    Turpie AG, Kreutz R, Llau J, Norrving B, Haas S.
    Thromb Haemost; 2012 Nov 22; 108(5):876-86. PubMed ID: 23014816
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Management of major bleeding complications and emergency surgery in patients on long-term treatment with direct oral anticoagulants, thrombin or factor-Xa inhibitors: proposals of the working group on perioperative haemostasis (GIHP) - March 2013.
    Pernod G, Albaladejo P, Godier A, Samama CM, Susen S, Gruel Y, Blais N, Fontana P, Cohen A, Llau JV, Rosencher N, Schved JF, de Maistre E, Samama MM, Mismetti P, Sié P, Working Group on Perioperative Haemostasis.
    Arch Cardiovasc Dis; 2013 Nov 22; 106(6-7):382-93. PubMed ID: 23810130
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.